Literature DB >> 24481247

Intraoperative monitoring of bladder and internal anal sphincter innervation: a predictor of erectile function following low anterior rectal resection for rectal cancer? Results of a prospective clinical study.

Werner Kneist1, Daniel W Kauff, Peter Rubenwolf, Christian Thomas, Christian Hampel, Hauke Lang.   

Abstract

BACKGROUND: The objective was to investigate whether two-dimensional intraoperative neuromonitoring (IONM) of pelvic autonomic nerves has the potential to predict erectile function (EF) following surgery for rectal cancer.
METHODS: A consecutive series of 17 sexually active male rectal cancer patients undergoing IONM-based nerve-sparing low anterior rectal resection were evaluated prospectively. IONM was performed by electric stimulation of the pelvic splanchnic nerves with concomitant electromyography of the internal anal sphincter and cystomanometry. Sexual function was assessed using a validated questionnaire.
RESULTS: The degree of agreement between electromyography-based and cystomanometry-based IONM with postoperative EF was moderate and good (κ = 0.43 and κ = 0.66). Combined assessment yielded the best agreement (κ = 0.76) with sensitivity of 90%, specificity of 86%, positive predictive value of 90%, negative predictive value of 86%, and overall accuracy of 88%, respectively, in terms of prediction of postoperative EF.
CONCLUSION: The method may be suitable to predict male EF following rectal resection. 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24481247     DOI: 10.1159/000357349

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  8 in total

1.  Midterm functional results of taTME with neuromapping for low rectal cancer.

Authors:  W Kneist; N Wachter; M Paschold; D W Kauff; A D Rink; H Lang
Journal:  Tech Coloproctol       Date:  2015-11-11       Impact factor: 3.781

Review 2.  Intraoperative neuromonitoring in rectal cancer surgery: a systematic review and meta-analysis.

Authors:  Athina A Samara; Ioannis Baloyiannis; Konstantinos Perivoliotis; Dimitrios Symeonidis; Alexandros Diamantis; Konstantinos Tepetes
Journal:  Int J Colorectal Dis       Date:  2021-03-08       Impact factor: 2.571

3.  Electrophysiology-based quality assurance of nerve-sparing in laparoscopic rectal cancer surgery: Is it worth the effort?

Authors:  D W Kauff; N Wachter; R Bettzieche; H Lang; W Kneist
Journal:  Surg Endosc       Date:  2016-02-19       Impact factor: 4.584

4.  Technique of neuromonitoring during pelvic peritonectomy.

Authors:  Antonio Macrì; Giorgio Badessi; Carmelo Mazzeo; Marica Galati; Eugenio Cucinotta; Vincenzo Rizzo
Journal:  Pleura Peritoneum       Date:  2020-08-25

5.  Prevalence of erectile dysfunction in male survivors of cancer: a systematic review and meta-analysis of cross-sectional studies.

Authors:  Damiano Pizzol; Tao Xiao; Lee Smith; Guillermo F López Sánchez; Andrea Garolla; Christopher Parris; Yvonne Barnett; Petre Cristian Ilie; Pinar Soysal; Jae Il Shin; Mark A Tully; Lin Yang; Nicola Veronese; Igor Grabovac
Journal:  Br J Gen Pract       Date:  2021-04-29       Impact factor: 5.386

6.  Continuous intraoperative monitoring of pelvic autonomic nerves during TME to prevent urogenital and anorectal dysfunction in rectal cancer patients (NEUROS): a randomized controlled trial.

Authors:  D W Kauff; K Kronfeld; S Gorbulev; D Wachtlin; H Lang; W Kneist
Journal:  BMC Cancer       Date:  2016-05-21       Impact factor: 4.430

7.  Pelvic intraoperative neuromonitoring during robotic-assisted low anterior resection for rectal cancer.

Authors:  Marian Grade; Alexander W Beham; P Schüler; Werner Kneist; B Michael Ghadimi
Journal:  J Robot Surg       Date:  2015-12-24

8.  Intraoperative monitoring of pelvic autonomic nerves during laparoscopic low anterior resection of rectal cancer.

Authors:  Min-Wei Zhou; Xiao-Yun Huang; Zong-You Chen; Zhen-Yang Li; Yi-Ming Zhou; Yi Yang; Zi-Hao Wang; Jian-Bin Xiang; Xiao-Dong Gu
Journal:  Cancer Manag Res       Date:  2018-12-31       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.